| Promoter hypermethylation analysis of host genes in cervical intraepithelial neoplasia and cervical cancers on histological cervical specimens L Shi, X Yang, L He, C Zheng, Z Ren, JA Warsame, S Suye, L Yan, H Cai, ... BMC cancer 23 (1), 168, 2023 | 15 | 2023 |
| Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis R Huang, L Yu, C Zheng, Q Liang, S Suye, X Yang, H Yin, Z Ren, L Shi, ... Scientific Reports 10 (1), 14975, 2020 | 13 | 2020 |
| The potential feasibility of nab-paclitaxel as the first-line chemotherapy for ovarian cancer: clinical development and future perspectives X Yang, C Fu Archives of Gynecology and Obstetrics 306 (5), 1417-1429, 2022 | 7 | 2022 |
| Inhibition of LIFR blocks adiposity-driven endometrioid endometrial cancer growth L Blankenship, UP Pratap, X Yang, Z Liu, KA Altwegg, B Santhamma, ... Cancers 14 (21), 5400, 2022 | 6 | 2022 |
| PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis X Yang, Z Liu, W Tang, UP Pratap, AB Collier, KA Altwegg, R Gopalam, ... Molecular oncology 18 (9), 2136-2156, 2024 | 4 | 2024 |
| The LIFR Inhibitor EC359 Effectively Targets Type II Endometrial Cancer by Blocking LIF/LIFR Oncogenic Signaling N Spencer, AL Rodriguez Sanchez, R Gopalam, P Subbarayalu, ... International journal of molecular sciences 24 (24), 17426, 2023 | 4 | 2023 |
| Preclinical development of brain permeable ERβ agonist for the treatment of glioblastoma UP Pratap, M Tidwell, HU Balinda, NA Clanton, X Yang, ... Molecular cancer therapeutics 22 (11), 1248-1260, 2023 | 4 | 2023 |
| Optical Coherence Tomography Can Reduce Colposcopic Referral Rates in Patients With High-Risk Human Papillomavirus X Xiao, L Yan, X Yang, Z Zhou, L Shi, C Fu Journal of Lower Genital Tract Disease 27 (4), 324-330, 2023 | 4 | 2023 |
| Pharmacological inhibition of the LIF/LIFR autocrine loop reveals vulnerability of ovarian cancer cells to ferroptosis B Ebrahimi, S Viswanadhapalli, UP Pratap, G Rahul, X Yang, ... NPJ Precision Oncology 8 (1), 118, 2024 | 3 | 2024 |
| Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34 KA Altwegg, UP Pratap, Z Liu, J Liu, JR Sanchez, X Yang, B Ebrahimi, ... Breast Cancer Research and Treatment 200 (1), 151-162, 2023 | 3 | 2023 |
| Effectiveness of TruScreen for detecting CIN2+ in women with ThinPrep cytologic test results indicating atypical squamous cells of undetermined significance and low-grade … X Yang, L He, X Xiao, L Yan, L Shi, Z Ren, H Cai, C Fu Future Oncology 19 (37), 2493-2504, 2023 | 2 | 2023 |
| PELP1 is a novel therapeutic target in hepatocellular carcinoma KM Nassar, X Yang, A Baker, R Gopalam, WC Arnold, TT Adeniran, ... Cancer Research Communications 4 (10), 2610-2620, 2024 | 1 | 2024 |
| Efficacy of optical coherence tomography in the triage of women with minor abnormal cervical cytology before colposcopy L Yan, X Xiao, L He, L Shi, X Yang, J Zhang, Y Zhang, C Fu Plos one 18 (3), e0282833, 2023 | 1 | 2023 |
| Novel LIPA-Targeted Therapy for Treating Ovarian Cancer AB Collier, S Viswanadhapalli, R Gopalam, TK Lee, K Kassees, K Parra, ... Cancers 16 (3), 500, 2024 | | 2024 |
